Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in l-NAME-induced hypertension

Cardiovascular Research

Volumn 101, Issue 3, 2014, Pages 464-472

  Sollinger, Daniel ^a   Eißler, Ruth ^b   Lorenz, Steffen ^a   Strand, Susanne ^a   Chmielewski, Stefan ^b,c   Aoqui, Cristiane ^b   Schmaderer, Christoph ^b   Bluyssen, Hans ^c   Zicha, Josef ^d   Witzke, Oliver ^e   Scherer, Elias ^b   Lutz, Jens ^a   Heemann, Uwe ^b   Baumann, Marcus ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Faculty of Biology   (Poland)

^d INSTITUTE OF MATHEMATICS   (Czech Republic)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Hypertension; Innate immunity; Reactive oxygen species; Toll like receptor; Vascular contractility

Indexed keywords

HYPERTENSION; INNATE IMMUNITY; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTOR; VASCULAR CONTRACTILITY;

ANIMALS; BLOOD VESSELS; CYCLIC GMP; HYPERTENSION; INFLAMMATION; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84894562923     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt265     Document Type: Article

References (30)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
2. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-2460.
3. De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005;25:2106-2113.
4. Eissler R, Schmaderer C, Rusai K, Kuhne L, Sollinger D, Lahmer T et al. Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res 2011;34: 551-558.
5. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007;27:84-91.
6. Arnal JF, Warin L, Michel JB. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992;90: 647-652.
7. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992;20:298-303.
8. Kato H, HouJ, ChobanianAV, Brecher P. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. Hypertension 1996;28:153-158.
9. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res 1995;76:30-39.
10. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74:1133-1140.
11. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al.HMG-1as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
12. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-7377.
13. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476-480.
14. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009;182: 7997-8004.
15. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A et al. NO-independent regulatory site on soluble guanylate cyclase. Nature 2001;410: 212-215.
16. Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C et al. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 2010; 25:853-860.
17. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
18. Kobayashi M, Inoue K, Warabi E, Minami T, Kodama T. A simple method of isolating mouse aortic endothelial cells. J Atheroscler Thromb 2005;12:138-142.
19. El-Awady MS, Smirnov SV, Watson ML. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta. Br J Pharmacol 2008;155:1164-1173.
20. Chen R, Iwai M, Wu L, Suzuki J, Min LJ, Shiuchi Tet al. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury. Hypertension 2003;42:542-547.
21. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007;100:1589-1596.
22. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4-and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009;104:210-218.
23. HsiehNK, Wang JY, Liu JC, Wang SD, Chen HI. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats. Clin Exp Pharmacol Physiol 2004;31: 212-218.
24. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, OchaniM, Li J et al.Acritical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010;107:11942-11947.
25. Tsung A, Sahai R, Tanaka H, Nakao A, FinkMP, LotzeMTet al. The nuclear factorHMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201: 1135-1143.
26. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR et al. Inflammation, immunity, and hypertension. Hypertension 2011;57:132-140.
27. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998;32:59-64.
28. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982;62:347-504.
29. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR et al. Inflammation, immunity, and hypertension. Hypertension 2011;57:132-140.
30. BomfimGF, Dos Santos RA, OliveiraMA, Giachini FR, Akamine EH, TostesRCet al. Tolllike receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond) 2012;122:535-543.